{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:01:06Z","timestamp":1790226066281,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Endoplasmic reticulum (ER) stress-mediated cell death contributes to many ocular diseases, including Fuchs corneal endothelial dystrophy (FECD). Natural compounds possess significant pharmacological activities necessary for vital cell signaling pathways and are considered protective in many ocular diseases such as diabetes, retinopathy, and glaucoma. However, there are limited studies examining the role of natural compounds in reducing sustained ER stress for improving corneal endothelial cell (CEnCs) survival. The purpose of this study is to identify readily available natural compounds to improve the viability of CEnCs under ER stress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human corneal endothelial cells (21T-HCEnC) were cultured and seeded in 384-well plates, pre-treated with 502 compounds from a natural product library (Enzo Screen-Well Natural Product library), and then subjected to ER stressor tunicamycin (1\u00b5g\/mL) for 24 hours. Cell viability was measured using the Cell-Titer-Glo assay, and 74 compounds improved viability past the set threshold (\u2265 30% increase in viability) and were selected for further dose-response testing. Further dose-response testing was performed using untreated F35T corneal endothelial cells, plated onto 384-well plates, and treated with a range of 6 log doses of each compound, from 10 pg\/mL up to 1 \u03bcg\/mL. After 24 hours of treatment, cell viability was measured again using the Cell-Titer Glo assay. Of the 4 natural compounds that improved viability past the set threshold at the lowest dose tested (0.00001 \u00b5g\/mL), veratrine was analyzed further via western blotting, ranging from 10 pg\/mL to 0.01 \u03bcg\/mL. Apoptotic and unfolded protein response markers were also measured via western blotting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 502 compounds each administered at 0.01 \u00b5g\/mL, we identified 74 compounds exhibiting 30% or more protection of 21T HCEnC cell viability in response to tunicamycin-induced stress. Of the 74 compounds that underwent further dose-response testing, 4 compounds improved cell viability by 30% or more at the lowest dose of compound tested compared to viability of F35T cells at baseline. Cevadine, or veratrine, was chosen for further analysis due to its function as a sodium channel agonist and its interaction with Na\n                      <jats:sup>+<\/jats:sup>\n                      \/K\n                      <jats:sup>+<\/jats:sup>\n                      ATPase channels. Pretreatment with veratrine 0.01 \u00b5g\/mL, along with tunicamycin, downregulated expression levels of cleaved caspase 9, PARP, cytochrome C, Bax, and cleaved caspase 3. Western blots of FECD cell line under tunicamycin-induced ER stress, pretreated with veratrine 0.01 \u00b5g\/mL, also showed reduced markers from all three ER unfolded protein response pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provided insight into the role of natural compounds in regulating ER stress-mediated CEnC death associated with many corneal endothelial-associated diseases. Veratrine was found to have a protective effect on ER-stressed CEnCs, as indicated by reduced apoptotic signals and ER stress markers following veratrine treatment, suggesting a possible mechanism of action via mediating ER stress signals. Future studies are needed to clarify the mechanism and utility of veratrine in FECD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fopht.2026.1945775","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:30:35Z","timestamp":1790224235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening of natural compounds library for protection against endoplasmic reticulum stress in corneal endothelial cells"],"prefix":"10.3389","volume":"6","author":[{"given":"Stephanie","family":"Lee","sequence":"first","affiliation":[{"name":"Eye and Vision Research Institute, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Kasi","sequence":"additional","affiliation":[{"name":"Eye and Vision Research Institute, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minwoo","family":"Kwon","sequence":"additional","affiliation":[{"name":"Eye and Vision Research Institute, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan Y.","family":"Kim","sequence":"additional","affiliation":[{"name":"Eye and Vision Research Institute, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Eye and Vision Research Institute, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Kumar","sequence":"additional","affiliation":[{"name":"Eye and Vision Research Institute, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai","place":["New York, NY, United States"]},{"name":"Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3091695","article-title":"Global prevalence of Fuchs endothelial corneal dystrophy (FECD) in adult population: A systematic review and meta-analysis","volume":"2022","author":"Aiello","year":"2022","journal-title":"J Ophthalmol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2021.100006","article-title":"Increased corneal endothelial cell migration in Fuchs endothelial corneal dystrophy: A live cell imaging study","volume":"1","author":"Ong Tone","year":"2021","journal-title":"Ophthalmol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70232-X","article-title":"Fuchs endothelial corneal dystrophy","volume":"8","author":"Elhalis","year":"2010","journal-title":"Ocul Surf"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-vision-091718-014852","article-title":"Fuchs endothelial corneal dystrophy: Clinical, genetic, pathophysiologic, and therapeutic aspects","volume":"5","author":"Matthaei","year":"2019","journal-title":"Annu Rev Vis Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.06.017","article-title":"The unfolded protein response and cell fate control","volume":"69","author":"Hetz","year":"2018","journal-title":"Mol Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: From stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ajo.2009.09.009","article-title":"Unfolded protein response in Fuchs endothelial corneal dystrophy: A unifying pathogenic pathway","volume":"149","author":"Engler","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.14.18","article-title":"Endoplasmic reticulum stress disrupts mitochondrial bioenergetics, dynamics and causes corneal endothelial cell apoptosis","volume":"64","author":"Qureshi","year":"2023","journal-title":"Investig Opthalmology Vis Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","article-title":"Endoplasmic reticulum stress: Molecular mechanism and therapeutic targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/febs.14522","article-title":"ER stress and unfolded protein response in ocular health and disease","volume":"286","author":"Kroeger","year":"2019","journal-title":"FEBS J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2013.08.053","article-title":"Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose","volume":"253","author":"Gaspar","year":"2013","journal-title":"Neuroscience"},{"key":"B12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nlm.2019.03.002","article-title":"Salubrinal offers neuroprotection through suppressing endoplasmic reticulum stress, autophagy and apoptosis in a mouse traumatic brain injury model","volume":"161","author":"Wang","year":"2019","journal-title":"Neurobiol Learn Mem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: Advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/549174","article-title":"Botanical compounds: Effects on major eye diseases","volume":"2013","author":"Huynh","year":"2013","journal-title":"Evid-Based Complement Altern Med ECAM"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30173592","article-title":"The role of nutraceuticals in age-related ocular diseases","volume":"30","author":"Starvaggi","year":"2025","journal-title":"Molecules"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.9.47","article-title":"Trinucleotide repeat-targeting dCas9 as a therapeutic strategy for Fuchs\u2019 endothelial corneal dystrophy","volume":"9","author":"Rong","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0022-3565(25)21861-4","article-title":"Action and mechanism of action of veratrine on renin secretion from rat kidney slices","volume":"229","author":"Churchill","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"B19","article-title":"Loss of ion transporters and increased unfolded protein response in Fuchs\u2019 dystrophy","volume":"20","author":"Jalimarada","year":"2014","journal-title":"Mol Vis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90850-p","article-title":"Na+ influx-induced decrease of (Na+ + K+)-ATPase activity in rat brain slices: Role of Ca2+","volume":"204","author":"Matsuda","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00301.x","article-title":"Actions of veratridine on tetrodotoxin-sensitive voltage-gated Na currents, Na1.6, in murine vas deferens myocytes","volume":"157","author":"Zhu","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3105251","article-title":"Herbal and natural treatments for the management of the glaucoma: An update","volume":"2023","author":"Vitiello","year":"2023","journal-title":"BioMed Res Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061138","article-title":"The role of natural products in diabetic retinopathy","volume":"12","author":"Zhao","year":"2024","journal-title":"Biomedicines"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001775.pub2","article-title":"Ginkgo biloba extract for age-related macular degeneration","volume":"2013","author":"Evans","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0393","article-title":"Emodin suppression of ocular surface inflammatory reaction","volume":"48","author":"Kitano","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10792-025-03513-6","article-title":"Emodin alleviates the damage to lens epithelial cells in diabetic cataract by repressing the p53-mediated ferroptosis pathway","volume":"45","author":"Zuo","year":"2025","journal-title":"Int Ophthalmol"},{"key":"B27","unstructured":"Dubinidine - Latoxan Valence France"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2024.109852","article-title":"Sphingolipid biosynthetic inhibitor L-cycloserine prevents oxidative-stress-mediated death in an in vitro model of photoreceptor-derived 661W cells","volume":"242","author":"Tahia","year":"2024","journal-title":"Exp Eye Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413389","article-title":"Inhibiting de novo biosynthesis of ceramide by L-cycloserine can prevent light-induced retinal degeneration in albino BALB\/c mice","volume":"25","author":"Tahia","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2000.00343.x","article-title":"Regulation of Na+,K+-ATPase by persistent sodium accumulation in adult rat thalamic neurones","author":"Senatorov","year":"2000","journal-title":"J Physiol"},{"key":"B31","article-title":"Moderate Fuchs\u2019 endothelial dystrophy ATPase pump site density","volume":"30","author":"McCartney","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703451","article-title":"Veratridine induces apoptotic death in bovine chromaffin cells through superoxide production","volume":"130","author":"Jord\u00e1n","year":"2000","journal-title":"Br J Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/biom16020239","article-title":"Suppressive functions of veratramine on PM2.5-induced oxidative stress","volume":"16","author":"Han","year":"2026","journal-title":"Biomolecules"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2006.02.009","article-title":"Effects of veratrine and veratridine on oxygen consumption and electrical membrane potential of isolated rat skeletal muscle and liver mitochondria","volume":"47","author":"Silva Freitas","year":"2006","journal-title":"Toxicon Off J Int Soc Toxinology"},{"key":"B35","unstructured":"EPA registers new pesticide active ingredient veratrine\n          \n          \n          \n          2025"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1945775\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:30:41Z","timestamp":1790224241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1945775\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":35,"alternative-id":["10.3389\/fopht.2026.1945775"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2026.1945775","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1945775"}}